NORDSON CORP, 10-Q filed on 2/20/2025
Quarterly Report
v3.25.0.1
Cover Page - shares
 3 Months Ended
Jan. 31, 2025
Feb. 18, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jan. 31, 2025  
Document Transition Report false  
Entity File Number 0-7977  
Entity Registrant Name NORDSON CORPORATION  
Entity Incorporation, State or Country Code OH  
Entity Tax Identification Number 34-0590250  
Entity Address, Address Line One 28601 Clemens Road  
Entity Address, City or Town Westlake  
Entity Address, State or Province OH  
Entity Address, Postal Zip Code 44145  
City Area Code 440  
Local Phone Number 892-1580  
Title of 12(b) Security Common Shares, without par value  
Trading Symbol NDSN  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   56,911,738
Amendment Flag false  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q1  
Entity Central Index Key 0000072331  
Current Fiscal Year End Date --10-31  
v3.25.0.1
Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Income Statement [Abstract]    
Sales $ 615,420 $ 633,193
Operating costs and expenses:    
Cost of sales 279,524 284,766
Selling and administrative expenses 194,949 188,992
Total operating costs and expenses 474,473 473,758
Operating profit 140,947 159,435
Other income (expense):    
Interest expense (26,559) (21,442)
Interest and investment income 941 1,044
Other income (expense) - net 1,526 (338)
Total other income (expense) (24,092) (20,736)
Income before income taxes 116,855 138,699
Income taxes 22,203 29,127
Net income $ 94,652 $ 109,572
Average common shares (in shares) 57,129 57,064
Incremental common shares attributable to equity compensation (in shares) 357 491
Average common shares attributable and common share equivalents (in shares) 57,486 57,555
Basic earnings per share (in dollars per share) $ 1.66 $ 1.92
Diluted earnings per share (in dollars per share) $ 1.65 $ 1.90
v3.25.0.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Statement of Comprehensive Income [Abstract]    
Net income $ 94,652 $ 109,572
Components of other comprehensive income (loss):    
Foreign currency translation adjustments (51,679) 43,943
Pension and other postretirement plan adjustments, net of tax 512 (459)
Total other comprehensive income (51,167) 43,484
Total comprehensive income $ 43,485 $ 153,056
v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2025
Oct. 31, 2024
Current assets:    
Cash and cash equivalents $ 130,424 $ 115,952
Receivables - net 531,298 594,663
Inventories - net 472,234 476,935
Prepaid expenses and other current assets 92,068 87,482
Total current assets 1,226,024 1,275,032
Goodwill 3,242,344 3,280,819
Intangible assets - net 704,496 740,846
Property, plant and equipment - net 538,448 544,607
Operating right of use lease assets 87,814 93,620
Deferred income taxes 11,748 11,196
Other assets 60,652 54,846
Total assets 5,871,526 6,000,966
Current liabilities:    
Current maturities of long-term debt and notes payable 101,063 103,928
Accrued liabilities 182,124 225,231
Accounts payable 88,546 97,839
Customer advanced payments 49,092 46,400
Income taxes payable 41,446 32,754
Operating lease liability - current 16,532 17,063
Finance lease liability - current 5,264 5,262
Total current liabilities 484,067 528,477
Long-term debt 2,085,177 2,101,197
Operating lease liability - noncurrent 75,497 80,818
Deferred income taxes 208,575 205,687
Postretirement obligations 51,406 51,544
Pension obligations 44,710 46,893
Finance lease liability - noncurrent 11,661 12,083
Other long-term liabilities 33,822 42,075
Shareholders' equity:    
Common shares 12,253 12,253
Capital in excess of stated value 719,073 714,091
Retained earnings 4,345,249 4,295,199
Accumulated other comprehensive loss (236,007) (184,840)
Common shares in treasury, at cost (1,963,957) (1,904,511)
Total shareholders' equity 2,876,611 2,932,192
Total liabilities and shareholders' equity $ 5,871,526 $ 6,000,966
v3.25.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Common Shares in Treasury, at cost
Beginning balance at Oct. 31, 2023 $ 2,598,060 $ 12,253 $ 668,097 $ 3,989,353 $ (196,441) $ (1,875,202)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued under company stock and employee benefit plans 14,418   12,519     1,899
Stock-based compensation 4,659   4,659      
Purchase of treasury shares (7,371)         (7,371)
Dividends declared (38,855)     (38,855)    
Net income 109,572     109,572    
Components of other comprehensive income (loss):            
Foreign currency translation adjustments 43,943       43,943  
Defined benefit pension and post-retirement plan adjustments (459)       (459)  
Ending balance at Jan. 31, 2024 2,723,967 12,253 685,275 4,060,070 (152,957) (1,880,674)
Beginning balance at Oct. 31, 2024 2,932,192 12,253 714,091 4,295,199 (184,840) (1,904,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued under company stock and employee benefit plans 1,001   349     652
Stock-based compensation 4,633   4,633      
Purchase of treasury shares (60,098)         (60,098)
Dividends declared (44,602)     (44,602)    
Net income 94,652     94,652    
Components of other comprehensive income (loss):            
Foreign currency translation adjustments (51,679)       (51,679)  
Defined benefit pension and post-retirement plan adjustments 512       512  
Ending balance at Jan. 31, 2025 $ 2,876,611 $ 12,253 $ 719,073 $ 4,345,249 $ (236,007) $ (1,963,957)
v3.25.0.1
Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Statement of Stockholders' Equity [Abstract]    
Dividends declared (in dollars per share) $ 0.78 $ 0.68
v3.25.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Cash flows from operating activities:    
Net income $ 94,652 $ 109,572
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 37,031 33,544
Non-cash stock compensation 4,633 4,659
Deferred income taxes (2,223) 1,642
Other non-cash expense 584 243
Loss on sale of property, plant and equipment 166 8
Changes in operating assets and liabilities and other 24,279 22,688
Net cash provided by operating activities 159,122 172,356
Cash flows from investing activities:    
Additions to property, plant and equipment (21,399) (7,530)
Proceeds from sale of property, plant and equipment 298 22
Other 6,825 1,783
Net cash used in investing activities (14,276) (5,725)
Cash flows from financing activities:    
Proceeds from issuance of debt 1,655 805
Repayment of debt (24,218) (108,000)
Repayment of finance lease obligations (1,320) (1,488)
Issuance of common shares in treasury 1,001 14,418
Purchase of treasury shares (60,098) (7,371)
Dividends paid (44,602) (38,855)
Net cash used in financing activities (127,582) (140,491)
Effect of exchange rate changes on cash (2,792) (5,618)
Increase in cash and cash equivalents 14,472 20,522
Cash and cash equivalents at beginning of period 115,952 115,679
Cash and cash equivalents at end of period $ 130,424 $ 136,201
v3.25.0.1
Significant accounting policies
 3 Months Ended
Jan. 31, 2025
Accounting Policies [Abstract]  
Significant accounting policies
Significant accounting policies
Basis of presentation.  The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles in the United States ("U.S. GAAP") for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended January 31, 2025 are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the Consolidated Financial Statements and notes included in our Annual Report on Form 10-K for the year ended October 31, 2024.
Consolidation.  The Condensed Consolidated Financial Statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50% or less or in which we do not have control but have the ability to exercise significant influence are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation.  
Use of estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements. Actual amounts could differ from these estimates.
Revenue recognition. A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. For products in which control transfers upon delivery, revenue is deferred for undelivered items and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of January 31, 2025 and October 31, 2024 were not material.
However, for certain contracts related to the sale of customer-specific products within our Medical and Fluid Solutions ("MFS") segment, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled, and we are contractually entitled to payment for work performed to date plus a reasonable margin.  
As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material on January 31, 2025 and October 31, 2024. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues for the year-to-date periods ended January 31, 2025 and October 31, 2024.
Revenue is measured as the amount of consideration we expect to be entitled to in exchange for transferring products or services. Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs, as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred, as the amortization period resulting from capitalizing the
costs is one year or less. These costs are recorded within Selling and administrative expenses in our Condensed Consolidated Statements of Income.
We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and is not material. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and therefore, these items are typically regarded as inconsequential or not material.
We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to our Operating segments Note for details.
Earnings per share.  Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted shares and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options excluded from the calculation of diluted earnings per share for the three months ended January 31, 2025 and 2024 were 193 and 74, respectively.
v3.25.0.1
Recently issued accounting standards
 3 Months Ended
Jan. 31, 2025
Accounting Changes and Error Corrections [Abstract]  
Recently issued accounting standards
Recently issued accounting standards
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 requires enhanced disclosures about significant segment expenses and enhanced disclosures in interim periods. The guidance in ASU 2023-07 will be applied retrospectively and is effective for annual reporting periods in fiscal years beginning after December 15, 2023 and interim reporting periods in fiscal years beginning after December 31, 2024, with early adoption permitted. The Company plans to adopt this standard beginning with our Annual Report on Form 10-K for the fiscal year ending October 31, 2025. While we expect the adoption of this standard will expand our disclosures related to our operating segments, we do not expect it to have any impact on our consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 is intended to improve income tax disclosure requirements by requiring specific disclosure in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The guidance in ASU 2023-09 will be effective for annual reporting periods in fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact that the adoption of ASU 2023-09 will have on its consolidated financial statements and disclosures and anticipates adoption in fiscal 2026.
In November 2024, the FASB issued ASU 2024-03, Income Statement (Topic 220): Reporting Comprehensive Income. ASU 2024-03 does not change or remove current expense presentation requirements within the Condensed Consolidated Statements of Income. However, the amendments require disclosure, on an annual and interim basis, disaggregated information about certain income statement expense line items within the notes to the consolidated financial statements. The ASU requires entities to disaggregate any relevant expense caption presented on the face of the income statement within continuing operations into expense categories such as: purchases of inventory, employee compensation, depreciation and intangible asset amortization. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact that the adoption of ASU 2024-03 will have on its consolidated financial statements and disclosures and anticipates adoption in fiscal 2028.
v3.25.0.1
Acquisitions
 3 Months Ended
Jan. 31, 2025
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Acquisitions
Acquisitions
Business acquisitions have been accounted for using the acquisition method, with the acquired assets and liabilities recorded at estimated fair value on the dates of acquisition. The cost in excess of the net assets of the business acquired is included in goodwill. Operating results since the respective dates of acquisitions are included in the Condensed Consolidated Statements of Income.
2024 Acquisition
On August 21, 2024, the Company completed the acquisition of Atrion Corporation, a Delaware corporation (“Atrion”), pursuant to the terms of the Agreement and Plan of Merger (the “Merger Agreement”), dated May 28, 2024, with Alpha Medical Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Nordson (“Merger Sub”), and Atrion. Pursuant to the Merger Agreement, Merger Sub merged with and into Atrion (the “Merger”), with Atrion surviving the Merger as a wholly owned subsidiary of Nordson. Atrion is a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions and will
operate within our MFS segment. The all-cash acquisition of Atrion of $789,996, net of cash acquired, was funded using borrowings under our revolving credit facility and the 364-day term loan agreement with a group of banks for a delayed draw term loan facility in the aggregate principal amount of $500,000 (the “364-Day Term Loan Agreement”) and cash on hand. Based on the fair value of the assets acquired and the liabilities assumed, a preliminary purchase price allocation resulted in the recognition of $494,409 of goodwill and $129,600 of identifiable intangible assets. The identifiable intangible assets consist primarily of $40,100 of tradenames (amortized over 15 years), $24,900 of technology (amortized over 15 years), and $64,600 of customer relationships (amortized over 19 years). Goodwill associated with the acquisition was not tax deductible. As of January 31, 2025, the purchase price allocation remains preliminary as we complete our assessment, principally related to income taxes. The financial results of the Atrion acquisition are not expected to have a material impact on our Consolidated Financial Statements.
The assets and liabilities acquired were as follows:
August 21, 2024
Cash$24,428 
Receivables - net20,883 
Inventories - net64,801 
Goodwill494,409 
Intangibles129,600 
Other assets158,059 
Total Assets$892,180 
Accounts payable$25,587 
Deferred income taxes31,221 
Other liabilities20,948 
Total Liabilities$77,756 
v3.25.0.1
Receivables
 3 Months Ended
Jan. 31, 2025
Credit Loss [Abstract]  
Receivables
Receivables
Our allowance for credit losses is principally determined based on aging of receivables. Receivables are exposed to credit risk based on the customers' ability to pay which is influenced by, among other factors, their financial liquidity. We perform ongoing customer credit evaluation to maintain sufficient allowances for potential credit losses. Our segments perform credit evaluation and monitoring to estimate and manage credit risk through the review of customer information, credit ratings, approval and monitoring of customer credit limits, and assessment of market conditions. We may also require prepayments or bank guarantees from customers to mitigate credit risk. Our receivables are generally short-term in nature with a majority of receivables outstanding less than 90 days. Accounts receivable balances are written-off against the allowance if deemed uncollectible.
Accounts receivable are net of an allowance for credit losses of $8,655 and $9,769 on January 31, 2025 and October 31, 2024, respectively. The provision income on receivables was $382 for the three months ended January 31, 2025, compared to the provision expense of $80 for the three months ended January 31, 2024. The remaining change in the allowance for credit losses is principally related to net write-off/recoveries of uncollectible accounts as well as currency translation.
v3.25.0.1
Inventories
 3 Months Ended
Jan. 31, 2025
Inventory Disclosure [Abstract]  
Inventories
Inventories
Components of inventories were as follows:
 January 31, 2025October 31, 2024
Finished goods$261,189 $256,465 
Raw materials and component parts248,264 250,477 
Work-in-process49,848 55,790 
 559,301 562,732 
Obsolescence and other reserves(87,067)(85,797)
 $472,234 $476,935 
v3.25.0.1
Property, Plant and Equipment
 3 Months Ended
Jan. 31, 2025
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment
Property, Plant and Equipment
Components of property, plant and equipment were as follows:
January 31, 2025October 31, 2024
Land$31,779 $32,018 
Land improvements4,802 4,822 
Buildings362,996 354,854 
Machinery and equipment645,577 649,510 
Enterprise management system53,662 53,401 
Construction-in-progress37,315 58,362 
Leased property under finance leases29,099 29,404 
 1,165,230 1,182,371 
Accumulated depreciation and amortization(626,782)(637,764)
 $538,448 $544,607 
Depreciation expense was $17,720 and $14,157 for the three months ended January 31, 2025 and 2024, respectively.
v3.25.0.1
Goodwill and other intangible assets
 3 Months Ended
Jan. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and other intangible assets
Goodwill and other intangible assets  
Changes in the carrying amount of goodwill for the three months ended January 31, 2025 by operating segment were as follows:
 Industrial
Precision
Solutions		Medical and Fluid SolutionsAdvanced
Technology
Solutions		Total
Balance at October 31, 2024$1,207,631 $1,669,748 $403,440 $3,280,819 
Acquisitions— 130 — 130 
Division transfer(29,010)29,010 — 
Currency effect(43,224)(1,930)6,549 (38,605)
Balance at January 31, 2025$1,135,397 $1,667,948 $438,999 $3,242,344 
Effective November 1, 2024, the Measurement and Control Solutions ("MCS") division was transferred from the Industrial Precision Solutions ("IPS") segment to the Advanced Technology Solutions ("ATS") segment due to an organizational change and determination that the economic and business characteristics of MCS better aligned with the Company’s ATS segment. The division transfer above reflects the transfer of goodwill from IPS to ATS as a result of this change.
In the first quarter of 2025, the Company also reassessed its reporting units for purposes of annual goodwill impairment testing due to a number of recent developments, including the status of integration activities associated with several significant acquisitions over the last few years and changes in the management of divisions, such as the transfer of MCS to the ATS segment. As a result of this reassessment and in consideration of the Company's management reporting structure, economic characteristics of the divisions and nature of the products and services of those divisions, the Company determined its reporting units should be the same as its operating segments: ATS, IPS and MFS. In accordance with ASC 350, Intangibles - Goodwill and Other, the Company properly assessed for indicators of impairment of goodwill at the time of the reporting unit change, concluding that no impairment existed.
Information regarding our intangible assets subject to amortization was as follows:
 January 31, 2025
 Carrying 
Amount		Accumulated
Amortization		Net Book 
Value
Customer relationships$860,096 $347,178 $512,918 
Patent/technology costs229,069 137,419 91,650 
Trade name165,183 65,306 99,877 
Non-compete agreements8,361 8,310 51 
Other430 430 — 
Total$1,263,139 $558,643 $704,496 
 October 31, 2024
 Carrying 
Amount		Accumulated
Amortization		Net Book 
Value
Customer relationships$878,071 $339,756 $538,315 
Patent/technology costs232,371 134,187 98,184 
Trade name167,144 62,887 104,257 
Non-compete agreements8,502 8,412 90 
Other500 500 — 
Total$1,286,588 $545,742 $740,846 
Amortization expense for the three months ended January 31, 2025 and 2024 was $19,311 and $19,387, respectively.
v3.25.0.1
Pension and other postretirement plans
 3 Months Ended
Jan. 31, 2025
Retirement Benefits [Abstract]  
Pension and other postretirement plans
Pension and other postretirement plans
The components of net periodic pension and other postretirement cost for the three months ended January 31, 2025 and 2024 were:
 U.S.International
Three Months Ended2025202420252024
Service cost$2,531 $2,507 $232 $237 
Interest cost4,691 4,752 623 689 
Expected return on plan assets(6,609)(6,652)(638)(417)
Amortization of prior service credit— — (2)(2)
Amortization of net actuarial (gain) loss474 — (67)9 
Total benefit cost$1,087 $607 $148 $516 
The components of other postretirement benefit costs for the three months ended January 31, 2025 and 2024 were:
 U.S.
Three Months Ended20252024
Service cost$59 $70 
Interest cost650 754 
Amortization of net actuarial gain(126)(147)
Total benefit cost (income)$583 $677 
The components of net periodic pension and other postretirement cost, other than service cost, are included in Other – net in our Condensed Consolidated Statements of Income.
v3.25.0.1
Income taxes
 3 Months Ended
Jan. 31, 2025
Income Tax Disclosure [Abstract]  
Income taxes
Income taxes
We record our interim provision for income taxes based on our estimated annual effective tax rate, as well as certain items discrete to the current period. The effective tax rate for the three months ended January 31, 2025 and 2024 was 19.0% and 21.0%, respectively. The effective tax rate for the three months ended January 31, 2025 is lower than the U.S. tax rate of 21% primarily due to the foreign-derived intangible income deduction.
v3.25.0.1
Accumulated other comprehensive loss
 3 Months Ended
Jan. 31, 2025
Equity [Abstract]  
Accumulated other comprehensive loss
Accumulated other comprehensive income (loss)
The components of accumulated other comprehensive income (loss), including adjustments for items that are reclassified from accumulated other comprehensive loss to net income, are shown below.
Cumulative
translation
adjustments		Pension and
postretirement 
benefit plan
adjustments		Accumulated
other 
comprehensive
income (loss)
Balance at October 31, 2024$(116,890)$(67,950)$(184,840)
Pension and other postretirement plan adjustments, net of tax of $163
— 512 512 
Foreign currency translation adjustments (a)
(51,679)— (51,679)
Balance at January 31, 2025$(168,569)$(67,438)$(236,007)
(a) Includes a net gain of $28,520, net of tax of $8,518, on net investment hedges.
v3.25.0.1
Stock-based compensation
 3 Months Ended
Jan. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-based compensation
Stock-based compensation
During the 2021 Annual Meeting of Shareholders, our shareholders approved the Nordson Corporation 2021 Stock Incentive and Award Plan (the "2021 Plan") as the successor to the Amended and Restated 2012 Stock Incentive and Award Plan (the "2012 Plan"). The 2021 Plan provides for the granting of stock options, stock appreciation rights, restricted shares, restricted share units, performance shares, cash awards and other stock or performance-based incentives. A maximum of 900 common shares were authorized for grant under the 2021 Plan plus the number of shares that remained available to be granted under the 2012 Plan, as well as issuable under the CyberOptics equity plan. As of January 31, 2025, a total of 1,718 common shares were available to be granted under the 2021 Plan.
Stock Options
Nonqualified or incentive stock options may be granted to our employees and directors. Generally, options granted to employees may be exercised beginning one year from the date of grant at a rate not exceeding 25 percent per year and expire 10 years from the date of grant. Vesting accelerates upon a qualified termination in connection with a change in control. In the event of termination of employment due to early retirement or normal retirement at age 65, options granted within 12 months prior to termination are forfeited, and vesting continues postretirement for all other unvested options granted. In the event of disability or death, all unvested stock options granted within 12 months prior to termination fully vest. Termination for any other reason results in forfeiture of unvested options and vested options in certain circumstances. The amortized cost of options is accelerated if the retirement eligibility date occurs before the normal vesting date. Option exercises are satisfied through the issuance of treasury shares on a first-in, first-out basis. We recognized compensation expense related to stock options of $748 and $1,088 for the three months ended January 31, 2025 and 2024, respectively.
The following table summarizes activity related to stock options for the three months ended January 31, 2025:
 Number of
Options		Weighted-
Average
Exercise Price 
Per Share		Aggregate
Intrinsic Value		Weighted
Average
Remaining
Term
Outstanding at October 31, 2024855$167.26 
Granted60209.73 
Exercised(10)114.34 
Forfeited or expired(1)238.80 
Outstanding at January 31, 2025904$170.65 $50,540 4.9 years
Expected to vest153$230.88 $631 8.8 years
Exercisable at January 31, 2025748$158.11 $49,889 4.0 years
As of January 31, 2025, there was $8,264 of total unrecognized compensation cost related to unvested stock options. That cost is expected to be amortized over a weighted average period of approximately 2.9 years.
The fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:
Three Months EndedJanuary 31, 2025January 31, 2024
Expected volatility30.3%-31.2%30.5%-31.7%
Expected dividend yield1.51%-1.51%1.15%-1.15%
Risk-free interest rate4.43%-4.48%4.22%-4.26%
Expected life of the option (in years)5.0-6.35.0-6.2
The weighted-average expected volatility used to value the 2025 and 2024 options was 30.5% and 30.7%, respectively.
Historical information was the primary basis for the selection of the expected volatility, expected dividend yield and the expected lives of the options. The risk-free interest rate was selected based upon yields of U.S. Treasury issues with a term equal to the expected life of the option being valued.
The weighted average grant date fair value of stock options granted during the three months ended January 31, 2025 and 2024 was $68.11 and $79.81, respectively.
The total intrinsic value of options exercised during the three months ended January 31, 2025 and 2024 was $1,351 and $14,127, respectively.
Cash received from the exercise of stock options for the three months ended January 31, 2025 and 2024 was $1,001 and $14,418, respectively.
Restricted Shares and Restricted Share Units
We may grant restricted shares and/or restricted share units to our employees and directors. These shares or units may not be transferred for a designated period of time (generally one to three years) defined at the date of grant. We may also grant continuation awards in the form of restricted share units with cliff vesting and a performance measure that must be achieved for the restricted share units to vest.
For employee recipients, in the event of termination of employment due to early retirement, with the consent of the Company, restricted shares and units granted within 12 months prior to termination are forfeited, and other restricted shares and units vest on a pro-rata basis, subject to the consent of the Compensation Committee. In the event of termination of employment due to normal retirement at age 65, restricted shares and units granted within 12 months prior to termination are forfeited, and, for other restricted shares and units, the restriction period applicable to restricted shares will lapse and the shares will vest and be transferable and all unvested units will become vested in full, subject to the consent of the Compensation Committee. In the event of a recipient's disability or death, all restricted shares and units granted within 12 months prior to termination fully vest. Termination for any other reason prior to the lapse of any restrictions or vesting of units results in forfeiture of the shares or units.
For non-employee directors, all restrictions lapse in the event of disability or death of the non-employee director. Termination of service as a director for any other reason within one year of date of grant results in a pro-rata vesting of shares or units.
As shares or units are issued, stock-based compensation equivalent to the fair value on the date of grant is expensed over the vesting period.  
The following table summarizes activity related to restricted share units during the three months ended January 31, 2025:
 Number of UnitsWeighted-Average
Grant Date
Fair Value
Restricted share units at October 31, 202467 $238.83 
Granted47 239.34
Forfeited(1)246.79
Vested(26)248.00
Restricted share units at January 31, 202587 $236.32 
As of January 31, 2025, there was $17,268 of remaining expense to be recognized related to outstanding restricted share units, which is expected to be recognized over a weighted average period of 2.1 years. The amount charged to expense related to restricted share units during each of the three months ended January 31, 2025 and 2024 was $2,510 and $2,226, respectively.
Performance Share Incentive Awards
Executive officers and selected other key employees are eligible to receive common share-based incentive awards. Payouts, in the form of unrestricted common shares, vary based on the degree to which corporate financial performance exceeds predetermined threshold, target and maximum performance goals over three-year performance periods. No payout will occur unless threshold performance is achieved.
The amount of compensation expense is based upon current performance projections and the percentage of the requisite service that has been rendered. The calculations are based upon the grant date fair value, which is principally driven by the stock price on the date of grant. The per share values were $199.30 in 2025 and $229.58 for 2024. The amount charged to expense related to performance awards for the three months ended January 31, 2025 and 2024 was $1,249 and $1,268, respectively. As of January 31, 2025, there was $11,984 of unrecognized compensation cost related to performance share incentive awards.
Deferred Compensation
Our executive officers and other highly compensated employees may elect to defer up to 100 percent of their base pay and cash incentive compensation, and for executive officers, up to 90 percent of their share-based performance incentive payout each year. Additional share units are credited for quarterly dividends paid on our common shares. Expense related to dividends paid under this plan for the three months ended January 31, 2025 and 2024 was $26 and $21, respectively.
Deferred Directors' Compensation
Non-employee directors may defer all or part of their cash and equity-based compensation until retirement. Cash compensation may be deferred as cash or as share equivalent units. Deferred cash amounts are recorded as liabilities, and share equivalent units are recorded as equity. Additional share equivalent units are earned when common share dividends are declared.
The following table summarizes activity related to director deferred compensation share equivalent units during the three months ended January 31, 2025:
 Number of SharesWeighted-Average
Grant Date 
Fair Value
Outstanding at October 31, 202465 $115.66 
Restricted stock units vested1 241.19 
Distributions(1)77.16 
Outstanding at January 31, 202565 $117.80 
The amount charged to expense related to director deferred compensation for the three months ended January 31, 2025 and 2024 was $100 and $56, respectively
v3.25.0.1
Warranties
 3 Months Ended
Jan. 31, 2025
Guarantees [Abstract]  
Warranties
Warranties
We offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) measured from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions is adjusted as necessary. The liability for warranty costs is included in Accrued liabilities in the Consolidated Balance Sheets.  
Following is a reconciliation of the product warranty liability for the three months ended January 31, 2025 and 2024:
 January 31, 2025January 31, 2024
Beginning balance at October 31$13,538 $14,401 
Accruals for warranties1,596 3,089 
Warranty payments(2,856)(2,663)
Currency effect(351)192 
Ending balance$11,927 $15,019 
v3.25.0.1
Operating segments
 3 Months Ended
Jan. 31, 2025
Segment Reporting [Abstract]  
Operating segments
Operating segments
We conduct business in three primary operating segments: IPS, MFS and ATS. The composition of segments and measure of segment profitability is consistent with that used by our chief operating decision maker. The primary measure used by the chief operating decision maker for purposes of making decisions about allocating resources to the segments and assessing performance is operating profit, which equals sales less cost of sales and certain operating expenses. Items below the operating profit line of the
Condensed Consolidated Statements of Income (interest and investment income, interest expense and other income/expense) are excluded from the measure of segment profitability reviewed by our chief operating decision maker and are not presented by operating segment. The accounting policies of the segments are the same as those described in the Significant accounting policies Note.
Effective November 1, 2024, the MCS division was transferred from the IPS segment to the ATS segment due to an organizational change and determination that the economic and business characteristics of MCS better aligned with the Company’s ATS segment. Our segment reporting reflects this change and prior year financial information was revised to be comparable.
Industrial Precision Solutions: This segment focuses on delivering proprietary dispensing and processing technology, both standard and highly customized equipment, to diverse end markets. Product lines commonly reduce material consumption, increase line efficiency through precision dispensing, and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This segment primarily serves the industrial, agricultural, consumer durables and non-durables markets.
Medical and Fluid Solutions: This segment includes the Company’s fluid management solutions for medical, high-tech industrial and other diverse end markets. Related plastic tubing, balloons, catheters, syringes, cartridges, tips and fluid connection components are used to dispense or control fluids within customers’ medical devices or products, as well as production processes.
Advanced Technology Solutions: This segment focuses on products serving electronics and consumer non-durable end markets. Advanced Technology Solutions products integrate our proprietary product technologies found in progressive stages of an electronics customer’s production and measurement and control processes, such as surface treatment, precisely controlled dispensing of material and test and inspection to ensure quality and reliability. Applications include, but are not limited to, semiconductors, printed circuit boards, electronic components, automotive electronics, in-line measurement sensors, gauges and analyzers.
The following table presents information about our segments:
Three Months EndedIndustrial
Precision
Solutions		Medical and Fluid SolutionsAdvanced
Technology
Solutions		CorporateTotal
January 31, 2025    
Net external sales$300,448 $193,609 $121,363 $— $615,420 
Operating profit (loss)95,712 40,936 18,123 (13,824)140,947 
January 31, 2024
Net external sales$337,742 $159,526 $135,925 $— $633,193 
Operating profit (loss)109,098 46,100 18,304 (14,067)159,435 
We had significant sales in the following geographic regions:
 Three Months Ended
 January 31, 2025January 31, 2024
Americas$267,836 $274,012 
Europe167,762 179,310 
Asia Pacific179,822 179,871 
Total net external sales$615,420 $633,193 
v3.25.0.1
Fair value measurements
 3 Months Ended
Jan. 31, 2025
Fair Value Disclosures [Abstract]  
Fair value measurements
Fair value measurements
The inputs to the valuation techniques used to measure fair value are classified into the following categories:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs that are not corroborated by market data.
The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis:
January 31, 2025TotalLevel 1Level 2Level 3
Assets:    
Foreign currency forward contracts (a)
$2,806 $— $2,806 $— 
Interest rate swaps (b)
2,985 — 2,985 — 
Net investment contracts (c)
18,796 — 18,796 — 
Total assets at fair value$24,587 $— $24,587 $— 
Liabilities:
Deferred compensation plans (d)
$10,791 $— $10,791 $— 
Foreign currency forward contracts (a)
9,345 — 9,345 — 
Net investment contracts (c)
96 — 96 — 
Total liabilities at fair value$20,232 $— $20,232 $— 
October 31, 2024TotalLevel 1Level 2Level 3
Assets:    
Foreign currency forward contracts (a)
$3,332 $— $3,332 $— 
Net investment contracts (c)
6,049 — 6,049 — 
Total assets at fair value$9,381 $— $9,381 $— 
Liabilities:
Deferred compensation plans (d)
$9,615 $— $9,615 $— 
Net investment contracts (c)
20,261 — 20,261 — 
Foreign currency forward contracts (a)
5,508 — 5,508 — 
Total liabilities at fair value$35,384 $— $35,384 $— 
(a)We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges.
(b)The Company is exposed to changes in the fair value of certain of its fixed-rate liabilities due to changes in benchmark interest rates. The Company uses interest rate swaps to manage its exposure to changes in fair value on these instruments attributable to changes in the designated benchmark interest rate, SOFR, with the objective of minimizing the cost of borrowed funds. The Company's interest rate swaps involve the receipt of fixed-rate amounts from a counterparty in exchange for the Company making variable-rate payments without the exchange of the underlying notional amount.
(c)Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. The fair value of these hedges is primarily based on the exchange rate between the currency pair of the hedge upon which settlement is based and includes an adjustment for the counterparty’s or Company’s credit risk. The notional amount of our net investment hedge contracts as of January 31, 2025 was $811,531.
(d)Executive officers and other highly compensated employees may defer up to 100% of their salary and annual cash incentive compensation and for executive officers, up to 90% of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.
The carrying amounts and fair values of financial instruments, other than cash and cash equivalents, receivables, accounts payable and notes payable, are shown in the table below. The carrying values of cash and cash equivalents, receivables, accounts payable and notes payable approximate fair value due to the short-term nature of these instruments.
 January 31, 2025
 Carrying AmountFair Value
Long-term debt (including current portion)$2,167,835 $2,185,944 
Long-term debt is valued by discounting future cash flows at currently available rates for borrowing arrangements with similar terms and conditions, which are considered to be Level 2 inputs under the fair value hierarchy. The carrying amount of long-term debt is shown net of unamortized debt issuance costs, bond discounts and interest rate swap fair value adjustment as disclosed in the Long-term debt Note.
v3.25.0.1
Derivative financial instruments
 3 Months Ended
Jan. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative financial instruments
Derivative financial instruments  
The Company uses derivative instruments to manage foreign currency and interest rate risk as detailed below.
Foreign Currency Forward Contracts
We operate internationally and enter into intercompany transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. Accordingly, the changes in the fair value of the foreign currency forward contracts are recognized in each accounting period in “Other – net” on the Condensed Consolidated Statements of Income together with the transaction gain or loss from the related balance sheet position. The settlement of these contracts is recorded in operating activities on the Condensed Consolidated Statement of Cash Flows.
For the three months ended January 31, 2025, we recognized a net loss of $4,363 on foreign currency forward contracts and a net gain of $4,694 from the change in fair value of balance sheet positions. For the three months ended January 31, 2024, we recognized a net gain of $12,094 on foreign currency forward contracts and a net loss of $12,916 from the change in fair value of balance sheet positions. The fair values of our foreign currency forward contract assets and liabilities are included in Receivable-net and Accrued liabilities, respectively, in our Consolidated Balance Sheets.
The following table summarizes, by currency, the foreign currency forward contracts outstanding at January 31, 2025 and 2024:
January 31, 2025 contract amounts:Notional Sell AmountsNotional Buy Amounts
Euro$138,952 $170,725 
British pound24,087 172,779 
Japanese yen22,217 24,307 
Mexican Peso37 25,260 
Hong Kong dollar1,844 2,528 
Singapore dollar8,313 21,376 
Australian dollar284 10,421 
Taiwan Dollar— 8,002 
Others10,977 75,638 
Total$206,711 $511,036 
January 31, 2024 contract amounts:Notional Sell AmountsNotional Buy Amounts
Euro$111,826 $96,737 
British pound19,136 180,224 
Mexican Peso925 33,885 
Japanese yen12,024 23,985 
Hong Kong dollar— 7,453 
Singapore dollar72 20,062 
Australian dollar— 9,334 
Taiwan Dollar— 8,000 
Others5,329 85,206 
Total$149,312 $464,886 
We are exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments. These financial instruments include cash deposits and foreign currency forward contracts. We periodically monitor the credit ratings of these
counterparties in order to minimize our exposure. Our customers represent a wide variety of industries and geographic regions. For the three months ended January 31, 2025 and 2024, there were no significant concentrations of credit risk.
Treasury Locks
During the fourth quarter of 2024, the Company entered into treasury locks to fix the interest rate related to $250,000 of the $600,000 aggregate principal amount of 2029 Notes issued on September 4, 2024. The derivative positions were closed when the debt was priced on September 4, 2024 with a cash settlement net payment of $2,306 that offset changes in the benchmark treasury rate between execution of the treasury rate locks and the debt pricing date. These derivatives were designed as cash flow hedges and the deferred amount reported in AOCI is being reclassed to interest expense as payments are made on the notes through the maturity date.
Net Investment Hedges
Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We may utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries.
As of January 31, 2025, the Company was party to various cross currency swaps between the U.S. Dollar and Euro, Japanese Yen, Taiwan Dollar, Singapore Dollar and Chinese Yuan, which were designated as hedges of our net investments in certain foreign subsidiaries to mitigate the foreign exchange risk associated with certain investments in these subsidiaries. Any increases or decreases related to the remeasurement of the hedges are recorded in the currency translation component of Accumulated other comprehensive income (loss) within Shareholders' Equity in the Consolidated Balance Sheet until the sale or substantial liquidation of the underlying investments. A gain of $28,520, net of tax, and a $11,855 loss, net of tax, was recorded for the three months ended January 31, 2025 and 2024, respectively.
The following table summarizes the fair values of our net investment contracts designated as net investment hedges in the Company's Condensed Consolidated Balance Sheets as of January 31, 2025:
Prepaid expenses and other current assetsOther assetsAccrued liabilitiesOther long-term liabilities
Net investment contracts$14,482 $4,314 $— $96 
Fair Value Hedges of Interest Rate Risk
The Company is exposed to changes in the fair value of certain of its fixed-rate liabilities due to changes in benchmark interest rates. The Company uses interest rate swaps to manage its exposure to changes in fair value on these instruments attributable to changes in the designated benchmark interest rate, Secured Overnight Financing Rate ("SOFR"), with the objective of minimizing the cost of borrowed funds. The Company's interest rate swaps involve the receipt of fixed-rate amounts from a counterparty in exchange for the Company making variable-rate payments without the exchange of the underlying notional amount.
The Company's interest rate swaps are designated and qualify as fair value hedges. As a result, the interest rate swaps are measured at fair value and the carrying value of the hedged debt is adjusted for the change in value related to the exposure being hedged, with both adjustments offset to earnings. Accordingly, the earnings effect of an increase in the fair value of the interest rate swaps will be substantially offset by the earnings effect of the increase in the carrying value of the hedged debt. The net impact of fair value hedge accounting for interest rate swaps is recognized in Interest expense. A loss of $44, net of tax, was recorded for the three months ended January 31, 2025. The fair values of our interest rate swap assets are included in Prepaid expenses and other current assets and Other assets in our Consolidated Balance Sheets.
The following table provides information regarding the Company's outstanding interest rate derivatives that were used to hedge changes in fair value attributable to interest rate risk:
Interest rate swaps - notional amountCumulative adjustment to long-term debt from application of hedge accountingCarrying value of hedged debt
Interest rate swaps$300,000 $2,985 $302,985 
v3.25.0.1
Long-term debt
 3 Months Ended
Jan. 31, 2025
Debt Disclosure [Abstract]  
Long-term debt
Long-term debt
A summary of long-term debt is as follows:
 January 31, 2025October 31, 2024
Notes Payable $15,420 $18,285 
Revolving credit agreement, due 2028220,000 240,000 
Term loan due 2026280,000 280,000 
Senior notes, due 20258,500 8,500 
Senior notes, due 2025-202737,143 37,143 
Senior notes, due 2025-2030190,000 190,000 
5.600% Notes due 2028350,000 350,000 
5.800% Notes due 2033500,000 500,000 
4.500% Notes due 2029600,000 600,000 
 2,201,063 2,223,928 
Less current maturities101,063 103,928 
Less unamortized debt issuance costs15,459 16,359 
Less bond discounts2,349 2,444 
Plus impact of interest rate swaps2,985 — 
Long-term maturities$2,085,177 $2,101,197 
Revolving credit agreement — In April 2019, we entered into a $850,000 unsecured multi-currency credit facility with a group of banks, which amended, restated and extended our then existing syndicated revolving credit agreement. This facility had a five-year term expiring in April 2024 and included a $75,000 sub-facility for swing-line loans. On April 17, 2023, we entered into an amendment to, among other things, replace London Interbank Offered Rate with the SOFR, the Euro Interbank Offered Rate, the Sterling Overnight Index Average and the Tokyo Interbank Offered Rate for U.S. Dollar, Euro, British Pound Sterling and Japanese Yen borrowings, respectively. On June 6, 2023, this credit agreement was terminated and replaced by the New Credit Agreement (as defined below).
In June 2023, we entered into a $1,150,000 unsecured multi-currency credit facility with a group of banks, which provides for a term loan facility in the aggregate principal amount of $300,000 (the "Term Loan Facility"), maturing in June 2026, and a multicurrency revolving credit facility in the aggregate principal amount of $850,000 (the "Revolving Facility"), maturing in June 2028 (the "New Credit Agreement"). In June 2024, the Revolving Facility was amended to increase the aggregate principal amount to $922,500. The Company borrowed and has outstanding $280,000 on the Term Loan Facility and $220,000 on the Revolving Facility as of January 31, 2025. The Revolving Facility permits borrowing in U.S. Dollars, Euros, Sterling, Swiss Francs, Singapore Dollars, Yen, and each other currency approved by a Revolving Facility lender. The New Credit Agreement provides that the applicable margin for (i) Risk-Free Rate ("RFR"), as defined in the New Credit Agreement, and Eurodollar Loans will range from 0.85% to 1.20% and (ii) Base Rate Loans will range from 0.00% to 0.20%, in each case, based on the Company’s Leverage Ratio (as defined in the New Credit Agreement and calculated on a consolidated net debt basis). Borrowings under the New Credit Agreement bear interest at (i) either a base rate or a SOFR rate, with respect to borrowings in U.S. dollars, (ii) a eurocurrency rate, with respect to borrowings in Euros and Yen, or (iii) Daily Simple RFR, with respect to borrowings in Sterling, Swiss Francs or Singapore Dollars, plus, in each case, an applicable margin (and, solely in the case of Singapore Dollars, a spread adjustment). The applicable margin is based on the Company’s Leverage Ratio. The weighted-average interest rate at January 31, 2025 was 5.83%.
Senior notes, due 2025 — These unsecured fixed-rate notes entered into in 2012 with a group of insurance companies have a remaining weighted-average life of 0.48 years. The weighted-average interest rate at January 31, 2025 was 3.07%.
Senior notes, due 2025-2027 — These unsecured fixed-rate notes entered into in 2015 with a group of insurance companies have a remaining weighted-average life of 1.30 years. The weighted-average interest rate at January 31, 2025 was 3.13%.
Senior notes, due 2025-2030 — These unsecured fixed-rate notes entered into in 2018 with a group of insurance companies have a remaining weighted-average life of 2.44 years. The weighted-average interest rate at January 31, 2025 was 4.03%.  
5.600% Notes due 2028 and 5.800% Notes due 2033 — In September 2023, we completed an underwritten public offering of $350,000 aggregate principal amount of 5.600% Notes due 2028 and $500,000 aggregate principal amount of 5.800% Notes due 2033.
4.500% Notes due 2029 — In September 2024, we completed an underwritten public offering of $600,000 aggregate principal amount of 4.500% Notes due 2029 (the "2029 Notes").
We were in compliance with all covenants at January 31, 2025, and the amount we could borrow would not have been limited by any debt covenants.
v3.25.0.1
Contingencies
 3 Months Ended
Jan. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Contingencies
Contingencies
We are involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee and other matters arising from the normal course of business. Including the environmental matter discussed below, after consultation with legal counsel, we do not believe that losses in excess of the amounts we have accrued would have a material adverse effect on our financial condition, quarterly or annual operating results or cash flows.
Environmental
We have voluntarily agreed with the City of New Richmond, Wisconsin and other potentially responsible parties to share costs associated with the remediation of the City of New Richmond municipal landfill (the “Site”) and the construction of a potable water delivery system serving the impacted area down gradient of the Site. As of January 31, 2025 and October 31, 2024, our accrual for the ongoing operation, maintenance and monitoring obligation at the Site was immaterial. The liability for environmental remediation represents management’s best estimate of the probable and reasonably estimable undiscounted costs related to known remediation obligations. The accuracy of our estimate of environmental liability is affected by several uncertainties such as additional requirements that may be identified in connection with remedial activities, the complexity and evolution of environmental laws and regulations, and the identification of presently unknown remediation requirements. Consequently, our liability could be greater than our current estimate. However, we do not expect that the costs associated with remediation will have a material adverse effect on our financial condition or results of operations.
v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Pay vs Performance Disclosure    
Net income $ 94,652 $ 109,572
v3.25.0.1
Insider Trading Arrangements
 3 Months Ended
Jan. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.0.1
Significant accounting policies (Policies)
 3 Months Ended
Jan. 31, 2025
Accounting Policies [Abstract]  
Basis of presentation Basis of presentation.  The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles in the United States ("U.S. GAAP") for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended January 31, 2025 are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the Consolidated Financial Statements and notes included in our Annual Report on Form 10-K for the year ended October 31, 2024.
Consolidation Consolidation.  The Condensed Consolidated Financial Statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50% or less or in which we do not have control but have the ability to exercise significant influence are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of estimates
Use of estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements. Actual amounts could differ from these estimates.
Revenue recognition
Revenue recognition. A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. For products in which control transfers upon delivery, revenue is deferred for undelivered items and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of January 31, 2025 and October 31, 2024 were not material.
However, for certain contracts related to the sale of customer-specific products within our Medical and Fluid Solutions ("MFS") segment, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled, and we are contractually entitled to payment for work performed to date plus a reasonable margin.  
As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material on January 31, 2025 and October 31, 2024. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues for the year-to-date periods ended January 31, 2025 and October 31, 2024.
Revenue is measured as the amount of consideration we expect to be entitled to in exchange for transferring products or services. Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs, as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred, as the amortization period resulting from capitalizing the
costs is one year or less. These costs are recorded within Selling and administrative expenses in our Condensed Consolidated Statements of Income.
We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and is not material. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and therefore, these items are typically regarded as inconsequential or not material.
We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to our Operating segments Note for details.
Earnings per share
Earnings per share.  Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted shares and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options excluded from the calculation of diluted earnings per share for the three months ended January 31, 2025 and 2024 were 193 and 74, respectively.
Recently issued accounting standards
Recently issued accounting standards
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 requires enhanced disclosures about significant segment expenses and enhanced disclosures in interim periods. The guidance in ASU 2023-07 will be applied retrospectively and is effective for annual reporting periods in fiscal years beginning after December 15, 2023 and interim reporting periods in fiscal years beginning after December 31, 2024, with early adoption permitted. The Company plans to adopt this standard beginning with our Annual Report on Form 10-K for the fiscal year ending October 31, 2025. While we expect the adoption of this standard will expand our disclosures related to our operating segments, we do not expect it to have any impact on our consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 is intended to improve income tax disclosure requirements by requiring specific disclosure in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The guidance in ASU 2023-09 will be effective for annual reporting periods in fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact that the adoption of ASU 2023-09 will have on its consolidated financial statements and disclosures and anticipates adoption in fiscal 2026.
In November 2024, the FASB issued ASU 2024-03, Income Statement (Topic 220): Reporting Comprehensive Income. ASU 2024-03 does not change or remove current expense presentation requirements within the Condensed Consolidated Statements of Income. However, the amendments require disclosure, on an annual and interim basis, disaggregated information about certain income statement expense line items within the notes to the consolidated financial statements. The ASU requires entities to disaggregate any relevant expense caption presented on the face of the income statement within continuing operations into expense categories such as: purchases of inventory, employee compensation, depreciation and intangible asset amortization. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact that the adoption of ASU 2024-03 will have on its consolidated financial statements and disclosures and anticipates adoption in fiscal 2028.
v3.25.0.1
Inventories (Tables)
 3 Months Ended
Jan. 31, 2025
Inventory Disclosure [Abstract]  
Schedule of Inventories
Components of inventories were as follows:
 January 31, 2025October 31, 2024
Finished goods$261,189 $256,465 
Raw materials and component parts248,264 250,477 
Work-in-process49,848 55,790 
 559,301 562,732 
Obsolescence and other reserves(87,067)(85,797)
 $472,234 $476,935 
v3.25.0.1
Property, Plant and Equipment (Tables)
 3 Months Ended
Jan. 31, 2025
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment
Components of property, plant and equipment were as follows:
January 31, 2025October 31, 2024
Land$31,779 $32,018 
Land improvements4,802 4,822 
Buildings362,996 354,854 
Machinery and equipment645,577 649,510 
Enterprise management system53,662 53,401 
Construction-in-progress37,315 58,362 
Leased property under finance leases29,099 29,404 
 1,165,230 1,182,371 
Accumulated depreciation and amortization(626,782)(637,764)
 $538,448 $544,607 
v3.25.0.1
Goodwill and other intangible assets (Tables)
 3 Months Ended
Jan. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of Changes in Carrying Amount of Goodwill
Changes in the carrying amount of goodwill for the three months ended January 31, 2025 by operating segment were as follows:
 Industrial
Precision
Solutions		Medical and Fluid SolutionsAdvanced
Technology
Solutions		Total
Balance at October 31, 2024$1,207,631 $1,669,748 $403,440 $3,280,819 
Acquisitions— 130 — 130 
Division transfer(29,010)29,010 — 
Currency effect(43,224)(1,930)6,549 (38,605)
Balance at January 31, 2025$1,135,397 $1,667,948 $438,999 $3,242,344 
Summary of Intangible Assets Subject to Amortization
Information regarding our intangible assets subject to amortization was as follows:
 January 31, 2025
 Carrying 
Amount		Accumulated
Amortization		Net Book 
Value
Customer relationships$860,096 $347,178 $512,918 
Patent/technology costs229,069 137,419 91,650 
Trade name165,183 65,306 99,877 
Non-compete agreements8,361 8,310 51 
Other430 430 — 
Total$1,263,139 $558,643 $704,496 
 October 31, 2024
 Carrying 
Amount		Accumulated
Amortization		Net Book 
Value
Customer relationships$878,071 $339,756 $538,315 
Patent/technology costs232,371 134,187 98,184 
Trade name167,144 62,887 104,257 
Non-compete agreements8,502 8,412 90 
Other500 500 — 
Total$1,286,588 $545,742 $740,846 
v3.25.0.1
Pension and other postretirement plans (Tables)
 3 Months Ended
Jan. 31, 2025
Retirement Benefits [Abstract]  
Components of Net Periodic Benefits Cost
The components of net periodic pension and other postretirement cost for the three months ended January 31, 2025 and 2024 were:
 U.S.International
Three Months Ended2025202420252024
Service cost$2,531 $2,507 $232 $237 
Interest cost4,691 4,752 623 689 
Expected return on plan assets(6,609)(6,652)(638)(417)
Amortization of prior service credit— — (2)(2)
Amortization of net actuarial (gain) loss474 — (67)9 
Total benefit cost$1,087 $607 $148 $516 
The components of other postretirement benefit costs for the three months ended January 31, 2025 and 2024 were:
 U.S.
Three Months Ended20252024
Service cost$59 $70 
Interest cost650 754 
Amortization of net actuarial gain(126)(147)
Total benefit cost (income)$583 $677 
v3.25.0.1
Accumulated other comprehensive loss (Tables)
 3 Months Ended
Jan. 31, 2025
Equity [Abstract]  
Summary of Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive income (loss), including adjustments for items that are reclassified from accumulated other comprehensive loss to net income, are shown below.
Cumulative
translation
adjustments		Pension and
postretirement 
benefit plan
adjustments		Accumulated
other 
comprehensive
income (loss)
Balance at October 31, 2024$(116,890)$(67,950)$(184,840)
Pension and other postretirement plan adjustments, net of tax of $163
— 512 512 
Foreign currency translation adjustments (a)
(51,679)— (51,679)
Balance at January 31, 2025$(168,569)$(67,438)$(236,007)
(a) Includes a net gain of $28,520, net of tax of $8,518, on net investment hedges.
v3.25.0.1
Stock-based compensation (Tables)
 3 Months Ended
Jan. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summarized Activity Related to Stock Options
The following table summarizes activity related to stock options for the three months ended January 31, 2025:
 Number of
Options		Weighted-
Average
Exercise Price 
Per Share		Aggregate
Intrinsic Value		Weighted
Average
Remaining
Term
Outstanding at October 31, 2024855$167.26 
Granted60209.73 
Exercised(10)114.34 
Forfeited or expired(1)238.80 
Outstanding at January 31, 2025904$170.65 $50,540 4.9 years
Expected to vest153$230.88 $631 8.8 years
Exercisable at January 31, 2025748$158.11 $49,889 4.0 years
Fair Value Assumptions of Stock Options
The fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:
Three Months EndedJanuary 31, 2025January 31, 2024
Expected volatility30.3%-31.2%30.5%-31.7%
Expected dividend yield1.51%-1.51%1.15%-1.15%
Risk-free interest rate4.43%-4.48%4.22%-4.26%
Expected life of the option (in years)5.0-6.35.0-6.2
Summarized Activity Related to Restricted Stock Units
The following table summarizes activity related to restricted share units during the three months ended January 31, 2025:
 Number of UnitsWeighted-Average
Grant Date
Fair Value
Restricted share units at October 31, 202467 $238.83 
Granted47 239.34
Forfeited(1)246.79
Vested(26)248.00
Restricted share units at January 31, 202587 $236.32 
Summarized Activity Related to Director Deferred Compensation Shares
The following table summarizes activity related to director deferred compensation share equivalent units during the three months ended January 31, 2025:
 Number of SharesWeighted-Average
Grant Date 
Fair Value
Outstanding at October 31, 202465 $115.66 
Restricted stock units vested1 241.19 
Distributions(1)77.16 
Outstanding at January 31, 202565 $117.80 
v3.25.0.1
Warranties (Tables)
 3 Months Ended
Jan. 31, 2025
Guarantees [Abstract]  
Reconciliation of Product Warranty Liability
Following is a reconciliation of the product warranty liability for the three months ended January 31, 2025 and 2024:
 January 31, 2025January 31, 2024
Beginning balance at October 31$13,538 $14,401 
Accruals for warranties1,596 3,089 
Warranty payments(2,856)(2,663)
Currency effect(351)192 
Ending balance$11,927 $15,019 
v3.25.0.1
Operating segments (Tables)
 3 Months Ended
Jan. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segments
The following table presents information about our segments:
Three Months EndedIndustrial
Precision
Solutions		Medical and Fluid SolutionsAdvanced
Technology
Solutions		CorporateTotal
January 31, 2025    
Net external sales$300,448 $193,609 $121,363 $— $615,420 
Operating profit (loss)95,712 40,936 18,123 (13,824)140,947 
January 31, 2024
Net external sales$337,742 $159,526 $135,925 $— $633,193 
Operating profit (loss)109,098 46,100 18,304 (14,067)159,435 
Sales and Long-lived Asset Information by Geographic Regions We had significant sales in the following geographic regions:
 Three Months Ended
 January 31, 2025January 31, 2024
Americas$267,836 $274,012 
Europe167,762 179,310 
Asia Pacific179,822 179,871 
Total net external sales$615,420 $633,193 
v3.25.0.1
Fair value measurements (Tables)
 3 Months Ended
Jan. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis:
January 31, 2025TotalLevel 1Level 2Level 3
Assets:    
Foreign currency forward contracts (a)
$2,806 $— $2,806 $— 
Interest rate swaps (b)
2,985 — 2,985 — 
Net investment contracts (c)
18,796 — 18,796 — 
Total assets at fair value$24,587 $— $24,587 $— 
Liabilities:
Deferred compensation plans (d)
$10,791 $— $10,791 $— 
Foreign currency forward contracts (a)
9,345 — 9,345 — 
Net investment contracts (c)
96 — 96 — 
Total liabilities at fair value$20,232 $— $20,232 $— 
October 31, 2024TotalLevel 1Level 2Level 3
Assets:    
Foreign currency forward contracts (a)
$3,332 $— $3,332 $— 
Net investment contracts (c)
6,049 — 6,049 — 
Total assets at fair value$9,381 $— $9,381 $— 
Liabilities:
Deferred compensation plans (d)
$9,615 $— $9,615 $— 
Net investment contracts (c)
20,261 — 20,261 — 
Foreign currency forward contracts (a)
5,508 — 5,508 — 
Total liabilities at fair value$35,384 $— $35,384 $— 
(a)We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges.
(b)The Company is exposed to changes in the fair value of certain of its fixed-rate liabilities due to changes in benchmark interest rates. The Company uses interest rate swaps to manage its exposure to changes in fair value on these instruments attributable to changes in the designated benchmark interest rate, SOFR, with the objective of minimizing the cost of borrowed funds. The Company's interest rate swaps involve the receipt of fixed-rate amounts from a counterparty in exchange for the Company making variable-rate payments without the exchange of the underlying notional amount.
(c)Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. The fair value of these hedges is primarily based on the exchange rate between the currency pair of the hedge upon which settlement is based and includes an adjustment for the counterparty’s or Company’s credit risk. The notional amount of our net investment hedge contracts as of January 31, 2025 was $811,531.
(d)Executive officers and other highly compensated employees may defer up to 100% of their salary and annual cash incentive compensation and for executive officers, up to 90% of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.
Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable The carrying values of cash and cash equivalents, receivables, accounts payable and notes payable approximate fair value due to the short-term nature of these instruments.
 January 31, 2025
 Carrying AmountFair Value
Long-term debt (including current portion)$2,167,835 $2,185,944 
v3.25.0.1
Derivative financial instruments (Tables) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Outstanding Currency, Forward Exchange Contracts
The following table summarizes, by currency, the foreign currency forward contracts outstanding at January 31, 2025 and 2024:
January 31, 2025 contract amounts:Notional Sell AmountsNotional Buy Amounts
Euro$138,952 $170,725 
British pound24,087 172,779 
Japanese yen22,217 24,307 
Mexican Peso37 25,260 
Hong Kong dollar1,844 2,528 
Singapore dollar8,313 21,376 
Australian dollar284 10,421 
Taiwan Dollar— 8,002 
Others10,977 75,638 
Total$206,711 $511,036 
January 31, 2024 contract amounts:Notional Sell AmountsNotional Buy Amounts
Euro$111,826 $96,737 
British pound19,136 180,224 
Mexican Peso925 33,885 
Japanese yen12,024 23,985 
Hong Kong dollar— 7,453 
Singapore dollar72 20,062 
Australian dollar— 9,334 
Taiwan Dollar— 8,000 
Others5,329 85,206 
Total$149,312 $464,886 
  
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location
The following table summarizes the fair values of our net investment contracts designated as net investment hedges in the Company's Condensed Consolidated Balance Sheets as of January 31, 2025:
Prepaid expenses and other current assetsOther assetsAccrued liabilitiesOther long-term liabilities
Net investment contracts$14,482 $4,314 $— $96 
  
Net Investment Hedge Gain (Loss) $ 28,520 $ (11,855)
Schedule of Interest Rate Derivatives
The following table provides information regarding the Company's outstanding interest rate derivatives that were used to hedge changes in fair value attributable to interest rate risk:
Interest rate swaps - notional amountCumulative adjustment to long-term debt from application of hedge accountingCarrying value of hedged debt
Interest rate swaps$300,000 $2,985 $302,985 
  
v3.25.0.1
Long-term debt (Tables)
 3 Months Ended
Jan. 31, 2025
Debt Disclosure [Abstract]  
Long-Term Debt
A summary of long-term debt is as follows:
 January 31, 2025October 31, 2024
Notes Payable $15,420 $18,285 
Revolving credit agreement, due 2028220,000 240,000 
Term loan due 2026280,000 280,000 
Senior notes, due 20258,500 8,500 
Senior notes, due 2025-202737,143 37,143 
Senior notes, due 2025-2030190,000 190,000 
5.600% Notes due 2028350,000 350,000 
5.800% Notes due 2033500,000 500,000 
4.500% Notes due 2029600,000 600,000 
 2,201,063 2,223,928 
Less current maturities101,063 103,928 
Less unamortized debt issuance costs15,459 16,359 
Less bond discounts2,349 2,444 
Plus impact of interest rate swaps2,985 — 
Long-term maturities$2,085,177 $2,101,197 
v3.25.0.1
Significant accounting policies - Additional Information (Detail) - shares
shares in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Significant Accounting Policies [Line Items]    
Less than 50% Ownership Percentage, Accounted for under the Equity Method of Investment 50.00%  
Stock Options    
Significant Accounting Policies [Line Items]    
Options for common shares excluded from computation of diluted earning per share (in shares) 193 74
v3.25.0.1
Acquisitions - Narrative (Detail) - USD ($)
Aug. 21, 2024
Jan. 31, 2025
Oct. 31, 2024
Business Acquisition [Line Items]      
Goodwill   $ 3,242,344,000 $ 3,280,819,000
364-Day Term Loan [Member]      
Business Acquisition [Line Items]      
Other Loans Payable, Current $ 500,000,000    
Atrion Corporation      
Business Acquisition [Line Items]      
Goodwill 494,409,000    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles 129,600,000    
All-cash transaction 789,996,000    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory 64,801,000    
Business Combination, Acquired Receivable, Fair Value 20,883,000    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other 158,059,000    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets 892,180,000    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable 25,587,000    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities 31,221,000    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other 20,948,000    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities 77,756,000    
Atrion Corporation | Trade name      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles $ 40,100,000    
Atrion Corporation | Trade name | Acquisitions In Two Thousand Twenty Three Member      
Business Acquisition [Line Items]      
Intangible assets amortization period 15 years    
Atrion Corporation | Technology-Based Intangible Assets      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles $ 24,900,000    
Atrion Corporation | Technology-Based Intangible Assets | Acquisitions In Two Thousand Twenty Three Member      
Business Acquisition [Line Items]      
Intangible assets amortization period 15 years    
Atrion Corporation | Customer relationships      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles $ 64,600,000    
Atrion Corporation | Customer relationships | Acquisitions In Two Thousand Twenty Three Member      
Business Acquisition [Line Items]      
Intangible assets amortization period 19 years    
v3.25.0.1
Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Aug. 21, 2024
Jan. 31, 2025
Oct. 31, 2024
Business Acquisition [Line Items]      
Goodwill   $ 3,242,344 $ 3,280,819
Atrion Corporation      
Business Acquisition [Line Items]      
Cash $ 24,428    
Business Combination, Acquired Receivable, Fair Value 20,883    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory 64,801    
Goodwill 494,409    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles 129,600    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other 158,059    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets 892,180    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable 25,587    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities 31,221    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other 20,948    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $ 77,756    
v3.25.0.1
Receivables (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Oct. 31, 2024
Credit Loss [Abstract]      
Accounts receivable, after allowance for credit loss $ 8,655   $ 9,769
Provisions for losses on receivables $ (382) $ (80)  
v3.25.0.1
Inventories - Schedule of Inventories (Detail) - USD ($)
$ in Thousands
Jan. 31, 2025
Oct. 31, 2024
Inventory Disclosure [Abstract]    
Finished goods $ 261,189 $ 256,465
Raw materials and component parts 248,264 250,477
Work-in-process 49,848 55,790
Inventories - gross 559,301 562,732
Obsolescence and other reserves (87,067) (85,797)
Inventories - net $ 472,234 $ 476,935
v3.25.0.1
Property, Plant and Equipment (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Oct. 31, 2024
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 1,165,230   $ 1,182,371
Accumulated depreciation and amortization (626,782)   (637,764)
Property, plant and equipment - net 538,448   544,607
Depreciation 17,720 $ 14,157  
Land      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 31,779   32,018
Land improvements      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 4,802   4,822
Buildings      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 362,996   354,854
Machinery and equipment      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 645,577   649,510
Enterprise management system      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 53,662   53,401
Construction-in-progress      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 37,315   58,362
Leased property under finance leases      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 29,099   $ 29,404
v3.25.0.1
Goodwill and other intangible assets - Summary of Changes in Carrying Amount of Goodwill (Detail)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 3,280,819
Acquisitions 130
Currency effect (38,605)
Ending balance 3,242,344
Industrial Precision Solutions  
Goodwill [Roll Forward]  
Beginning balance 1,207,631
Acquisitions 0
Currency effect (43,224)
Ending balance 1,135,397
Advanced Technology Solutions  
Goodwill [Roll Forward]  
Beginning balance 403,440
Acquisitions 0
Currency effect 6,549
Ending balance 438,999
Medical Fluid Systems  
Goodwill [Roll Forward]  
Beginning balance 1,669,748
Acquisitions 130
Currency effect (1,930)
Ending balance $ 1,667,948
v3.25.0.1
Goodwill and other intangible assets - Summary of Intangible Assets Subject to Amortization (Detail) - USD ($)
$ in Thousands
Jan. 31, 2025
Oct. 31, 2024
Finite-Lived Intangible Assets [Line Items]    
Carrying  Amount $ 1,263,139 $ 1,286,588
Accumulated Amortization 558,643 545,742
Net Book  Value 704,496 740,846
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Carrying  Amount 860,096 878,071
Accumulated Amortization 347,178 339,756
Net Book  Value 512,918 538,315
Patent/technology costs    
Finite-Lived Intangible Assets [Line Items]    
Carrying  Amount 229,069 232,371
Accumulated Amortization 137,419 134,187
Net Book  Value 91,650 98,184
Trade name    
Finite-Lived Intangible Assets [Line Items]    
Carrying  Amount 165,183 167,144
Accumulated Amortization 65,306 62,887
Net Book  Value 99,877 104,257
Non-compete agreements    
Finite-Lived Intangible Assets [Line Items]    
Carrying  Amount 8,361 8,502
Accumulated Amortization 8,310 8,412
Net Book  Value 51 90
Other    
Finite-Lived Intangible Assets [Line Items]    
Carrying  Amount 430 500
Accumulated Amortization 430 500
Net Book  Value $ 0 $ 0
v3.25.0.1
Goodwill and other intangible assets - Additional Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]    
Intangible assets, amortization expense $ 19,311 $ 19,387
v3.25.0.1
Pension and other postretirement plans - Net Periodic Benefit Cost (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Pension Plans | International    
Defined Benefit Plan Disclosure [Line Items]    
Service cost $ 232 $ 237
Interest cost 623 689
Expected return on plan assets (638) (417)
Amortization of prior service credit (2) (2)
Amortization of net actuarial gain (67) 9
Total benefit cost 148 516
Pension Plans | United States    
Defined Benefit Plan Disclosure [Line Items]    
Service cost 2,531 2,507
Interest cost 4,691 4,752
Expected return on plan assets (6,609) (6,652)
Amortization of prior service credit 0 0
Amortization of net actuarial gain 474 0
Total benefit cost 1,087 607
Postretirement Benefit Costs | United States    
Defined Benefit Plan Disclosure [Line Items]    
Service cost 59 70
Interest cost 650 754
Amortization of net actuarial gain (126) (147)
Total benefit cost $ 583 $ 677
v3.25.0.1
Income taxes (Detail)
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Income Tax Disclosure [Abstract]    
Effective tax rates 19.00% 21.00%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 21.00%  
v3.25.0.1
Accumulated other comprehensive loss - Summary of Accumulated Other Comprehensive Loss (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance $ 2,932,192 $ 2,598,060
Pension and other postretirement plan adjustments, net of tax of $163 (512)  
Foreign currency translation adjustments (a) (51,679) 43,943
Ending balance 2,876,611 2,723,967
Amortization of prior service costs and net actuarial losses, tax 163  
Other Comprehensive Income (Loss), Net Investment Hedge, Tax (8,518)  
Other Comprehensive Income (Loss), Net Investment Hedge, Gross 28,520  
Accumulated Other Comprehensive Income (Loss)    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (184,840) (196,441)
Foreign currency translation adjustments (a) (51,679) 43,943
Ending balance (236,007) $ (152,957)
Cumulative translation adjustments    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (116,890)  
Pension and other postretirement plan adjustments, net of tax of $163 0  
Foreign currency translation adjustments (a) (51,679)  
Ending balance (168,569)  
Pension and postretirement  benefit plan adjustments    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (67,950)  
Pension and other postretirement plan adjustments, net of tax of $163 (512)  
Foreign currency translation adjustments (a) 0  
Ending balance $ (67,438)  
v3.25.0.1
Stock-based compensation - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Oct. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Maximum number of common shares authorized for grant (in shares) 900,000    
Number of common shares available for grant (in shares) 1,718,000    
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum 100.00%    
Executive officers share-based long-term incentive compensation deferrals percentage, maximum 90.00%    
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Option expiring period 10 years    
Normal retirement age 65 years    
Period for options considered to be forfeited for retirees 12 months    
Termination period on death or disability of option holder 12 months    
Compensation expense recognized $ 748 $ 1,088  
Unrecognized compensation cost related to unvested stock option $ 8,264    
Weighted average period expected to be amortized, non vested shares 2 years 10 months 24 days    
Weighted-average expected volatility used 30.50% 30.70%  
Weighted average grant date fair value of stock options granted (in dollars per share) $ 68.11 $ 79.81  
Total intrinsic value of options exercised $ 1,351 $ 14,127  
Cash received from the exercise of stock options $ 1,001 14,418  
Stock Options | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Maximum rate of stock option 25.00%    
Restricted Shares and Restricted Share Units | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grant restricted shares transferred period 3 years    
Restricted Shares and Restricted Share Units | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grant restricted shares transferred period 1 year    
Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Normal retirement age 65 years    
Period for restricted shares and share units considered to be forfeited for retirees 12 months    
Restricted shares termination period for disability or death 12 months    
Restricted Stock Unit      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average period expected to be amortized, non vested shares 2 years 1 month 6 days    
Unrecognized compensation cost related to nonvested restricted stock $ 17,268    
Expense related to nonvested common shares $ 2,510 2,226  
Weighted average grant date fair value (in dollars per share) $ 236.32   $ 238,830
Performance Share Incentive Awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award requisite service period 3 years    
Compensation expense $ 1,249 $ 1,268  
Unrecognized compensation cost $ 11,984    
Performance Share Incentive Awards | Grant Date One      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average grant date fair value (in dollars per share) $ 199.30    
Performance Share Incentive Awards | Grant Date Two      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average grant date fair value (in dollars per share)   $ 229.58  
Deferred Compensation      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common share dividends amount included in compensation cost $ 26 $ 21  
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum 100.00%    
Executive officers share-based long-term incentive compensation deferrals percentage, maximum 90.00%    
Deferred Compensation | Directors      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expense related to director deferred compensation $ 100 $ 56  
v3.25.0.1
Stock-based compensation - Summarized Activity Related to Stock Options (Detail) - Stock Options
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended
Jan. 31, 2025
USD ($)
$ / shares
shares
Number of Options  
Beginning balance (in shares) | shares 855
Granted (in shares) | shares 60
Exercised (in shares) | shares (10)
Forfeited or expired (in shares) | shares (1)
Ending balance (in shares) | shares 904
Expected to vest (in shares) | shares 153
Exercisable (in shares) | shares 748
Weighted- Average Exercise Price  Per Share  
Beginning balance (in dollars per share) | $ / shares $ 167.26
Granted (in dollars per share) | $ / shares 209.73
Exercised (in dollars per share) | $ / shares 114.34
Forfeited or expired (in dollars per share) | $ / shares 238.80
Ending balance (in dollars per share) | $ / shares 170.65
Expected to vest (in dollars per share) | $ / shares 230.88
Exercisable (in dollars per share) | $ / shares $ 158.11
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Aggregate intrinsic value, outstanding | $ $ 50,540
Aggregate intrinsic value, expected to vest | $ 631
Aggregate intrinsic value, exercisable | $ $ 49,889
Weighted average remaining term, outstanding 4 years 10 months 24 days
Weighted average remaining term, expected to vest 8 years 9 months 18 days
Weighted average remaining term, exercisable 4 years
v3.25.0.1
Stock-based compensation - Fair Value Assumptions of Stock Options (Detail) - Stock Options
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expected volatility, minimum 30.30% 30.50%
Expected volatility, maximum 31.20% 31.70%
Risk-free interest rate, minimum 4.43% 4.22%
Risk-free interest rate, maximum 4.48% 4.26%
Minimum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expected dividend yield 1.51% 1.15%
Expected life of the option (in years) 5 years 5 years
Maximum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expected dividend yield 1.51% 1.15%
Expected life of the option (in years) 6 years 3 months 18 days 6 years 2 months 12 days
v3.25.0.1
Stock-based compensation - Summarized Activity Related to Restricted Stock Units (Detail) - Restricted Stock Unit - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance (in shares) 67  
Granted (in shares) 47  
Forfeited (in shares) (1)  
Vested (in shares) (26)  
Ending balance (in shares) 87  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance (in dollars per share) $ 238,830  
Granted (in dollars per share) 239.34  
Forfeited (in dollars per share) 246.79  
Vested (in dollars per share) 248.00  
Ending balance (in dollars per share) $ 236.32  
Expense related to nonvested common shares $ 2,510 $ 2,226
v3.25.0.1
Stock-based compensation - Summarized Activity Related to Director Deferred Compensation Shares (Detail) - Directors - Deferred Compensation Share Equivalent Units
shares in Thousands
 3 Months Ended
Jan. 31, 2025
$ / shares
shares
Number of Shares  
Outstanding, Beginning balance (in shares) | shares 65
Distributions (in shares) | shares (1)
Outstanding, Ending balance (in shares) | shares 65
Weighted-Average Grant Date  Fair Value  
Beginning balance (in dollars per share) | $ / shares $ 115.66
Distributions (in dollars per share) | $ / shares 77.16
Ending balance (in dollars per share) | $ / shares $ 117.80
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Restricted Stock Units Vested | shares 1
Share Based Compensation Arrangement By Share Based Payment Award Vested Equity Instruments Other Than Options Weighted Average Grant Date Fair Value Vested | $ / shares $ 241.19
v3.25.0.1
Warranties - Additional Information (Detail)
 3 Months Ended
Jan. 31, 2025
Guarantees [Abstract]  
Product warranty period 1 year
v3.25.0.1
Warranties - Reconciliation of Product Warranty Liability (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]    
Beginning balance $ 13,538 $ 14,401
Accruals for warranties 1,596 3,089
Warranty payments (2,856) (2,663)
Currency effect (351) 192
Ending balance $ 11,927 $ 15,019
v3.25.0.1
Operating segments - Additional Information (Detail)
 3 Months Ended
Jan. 31, 2025
segment
Segment Reporting [Abstract]  
Number of operating segments 3
v3.25.0.1
Operating segments - Segments (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Segment Reporting Information [Line Items]    
Net external sales $ 615,420 $ 633,193
Operating profit (loss) 140,947 159,435
Operating Segments    
Segment Reporting Information [Line Items]    
Net external sales 615,420 633,193
Operating profit (loss) 140,947 159,435
Operating Segments | Industrial Precision Solutions    
Segment Reporting Information [Line Items]    
Net external sales 300,448 337,742
Operating profit (loss) 95,712 109,098
Operating Segments | Advanced Technology Solutions    
Segment Reporting Information [Line Items]    
Net external sales 121,363 135,925
Operating profit (loss) 18,123 18,304
Operating Segments | Medical and Fluid Solutions    
Segment Reporting Information [Line Items]    
Net external sales 193,609 159,526
Operating profit (loss) 40,936 46,100
Corporate    
Segment Reporting Information [Line Items]    
Net external sales 0 0
Operating profit (loss) $ (13,824) $ (14,067)
v3.25.0.1
Operating segments - Sales Information by Geographic Regions (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]    
Net external sales $ 615,420 $ 633,193
Americas    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Net external sales 267,836 274,012
Europe    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Net external sales 167,762 179,310
Asia Pacific    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Net external sales $ 179,822 $ 179,871
v3.25.0.1
Fair value measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Recurring - USD ($)
$ in Thousands
Jan. 31, 2025
Oct. 31, 2024
Assets:    
Foreign currency forward contracts $ 2,806 $ 3,332
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) 2,985  
Net investment contracts 18,796 6,049
Total assets at fair value 24,587 9,381
Liabilities:    
Deferred compensation plans 10,791 9,615
Foreign currency forward contracts 9,345 5,508
Net investment contracts 96 20,261
Total liabilities at fair value 20,232 35,384
Level 1    
Assets:    
Foreign currency forward contracts 0 0
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) 0  
Net investment contracts 0 0
Total assets at fair value 0 0
Liabilities:    
Deferred compensation plans 0 0
Foreign currency forward contracts 0 0
Net investment contracts 0 0
Total liabilities at fair value 0 0
Level 2    
Assets:    
Foreign currency forward contracts 2,806 3,332
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) 2,985  
Net investment contracts 18,796 6,049
Total assets at fair value 24,587 9,381
Liabilities:    
Deferred compensation plans 10,791 9,615
Foreign currency forward contracts 9,345 5,508
Net investment contracts 96 20,261
Total liabilities at fair value 20,232 35,384
Level 3    
Assets:    
Foreign currency forward contracts 0 0
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) 0  
Net investment contracts 0 0
Total assets at fair value 0 0
Liabilities:    
Deferred compensation plans 0 0
Foreign currency forward contracts 0 0
Net investment contracts 0 0
Total liabilities at fair value $ 0 $ 0
v3.25.0.1
Fair value measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Additional Information) (Detail)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
USD ($)
Fair Value Disclosures [Abstract]  
Notional Amounts of foreign currency derivative contracts $ 811,531
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum 100.00%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum 90.00%
v3.25.0.1
Fair value measurements - Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable (Detail)
$ in Thousands
Jan. 31, 2025
USD ($)
Fair Value Disclosures [Abstract]  
Long-term debt, carrying amount $ 2,167,835
Long-term debt, fair value $ 2,185,944
v3.25.0.1
Derivative financial instruments - Additional Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Sep. 04, 2024
Jan. 31, 2025
Jan. 31, 2024
Oct. 31, 2024
Sep. 09, 2024
Derivative [Line Items]          
Maturity of foreign currency forward contracts   90 days      
Gains (losses) on foreign currency forward contracts   $ (4,363) $ 12,094    
Change in unrealized gain (loss) on foreign currency derivative instruments   4,694 $ (12,916)    
Derivative, Gain (Loss) on Derivative, Net   $ (44)      
Due 2029          
Derivative [Line Items]          
Treasury Lock $ 250,000        
Public Bond Offering 600,000     $ 600,000 $ 600,000
Treasury Lock Cash Settlement $ 2,306        
v3.25.0.1
Derivative financial instruments - Outstanding Currency, Forward Exchange Contracts (Details) - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts $ 811,531  
Foreign Currency Forward Contracts | Notional Sell Amounts    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 206,711 $ 149,312
Foreign Currency Forward Contracts | Notional Sell Amounts | Euro    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 138,952 111,826
Foreign Currency Forward Contracts | Notional Sell Amounts | British pound    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 24,087 19,136
Foreign Currency Forward Contracts | Notional Sell Amounts | Mexican Peso    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 37 925
Foreign Currency Forward Contracts | Notional Sell Amounts | Japanese yen    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 22,217 12,024
Foreign Currency Forward Contracts | Notional Sell Amounts | Hong Kong dollar    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 1,844 0
Foreign Currency Forward Contracts | Notional Sell Amounts | Australian dollar    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 284 0
Foreign Currency Forward Contracts | Notional Sell Amounts | Singapore dollar    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 8,313 72
Foreign Currency Forward Contracts | Notional Sell Amounts | Taiwan Dollar    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 0 0
Foreign Currency Forward Contracts | Notional Sell Amounts | Others    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 10,977 5,329
Foreign Currency Forward Contracts | Notional Sell Amounts    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 511,036 464,886
Foreign Currency Forward Contracts | Notional Sell Amounts | Euro    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 170,725 96,737
Foreign Currency Forward Contracts | Notional Sell Amounts | British pound    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 172,779 180,224
Foreign Currency Forward Contracts | Notional Sell Amounts | Mexican Peso    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 25,260 33,885
Foreign Currency Forward Contracts | Notional Sell Amounts | Japanese yen    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 24,307 23,985
Foreign Currency Forward Contracts | Notional Sell Amounts | Hong Kong dollar    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 2,528 7,453
Foreign Currency Forward Contracts | Notional Sell Amounts | Australian dollar    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 10,421 9,334
Foreign Currency Forward Contracts | Notional Sell Amounts | Singapore dollar    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 21,376 20,062
Foreign Currency Forward Contracts | Notional Sell Amounts | Taiwan Dollar    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts 8,002 8,000
Foreign Currency Forward Contracts | Notional Sell Amounts | Others    
Derivative [Line Items]    
Notional Amounts of foreign currency derivative contracts $ 75,638 $ 85,206
v3.25.0.1
Derivative financial instruments - Summary of Fair Values Of Net Investment Contracts (Details)
Jan. 31, 2025
USD ($)
Prepaid expenses and other current assets  
Derivative [Line Items]  
Net investment contracts $ 14,482,000
Other assets  
Derivative [Line Items]  
Net investment contracts 4,314,000
Accrued liabilities  
Derivative [Line Items]  
Net investment contracts 0
Other long-term liabilities  
Derivative [Line Items]  
Net investment contracts $ 96,000
v3.25.0.1
Derivative financial instruments - Schedule of Interest Rate Derivatives (Details)
$ in Thousands
Jan. 31, 2025
USD ($)
Derivative [Line Items]  
Interest Rate Swap, Notional Amount $ 300,000
Interest Rate Swap, Carrying Value $ 302,985
v3.25.0.1
Long-term debt - Long-Term Debt (Detail) - USD ($)
Jan. 31, 2025
Oct. 31, 2024
Sep. 09, 2024
Sep. 04, 2024
Sep. 13, 2023
Jun. 06, 2023
Apr. 30, 2019
Debt Instrument [Line Items]              
Long-term debt $ 2,201,063,000 $ 2,223,928,000          
Less current maturities 101,063,000 103,928,000          
Less unamortized debt issuance costs 15,459,000 16,359,000          
Long-term maturities 2,085,177,000 2,101,197,000          
Revolving credit facility           $ 1,150,000,000  
Debt Instrument, Unamortized Discount 2,349,000 2,444,000          
Short-Term Bank Loans and Notes Payable 15,420,000 18,285,000          
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) 2,985,000 0          
Senior notes, due 2025              
Debt Instrument [Line Items]              
Senior notes $ 8,500,000 8,500,000          
Weighted average interest rate for borrowings 3.07%            
Senior notes, due 2025-2027              
Debt Instrument [Line Items]              
Senior notes $ 37,143,000 37,143,000          
Weighted average interest rate for borrowings 3.13%            
Senior notes, due 2025-2030              
Debt Instrument [Line Items]              
Senior notes $ 190,000,000 190,000,000          
Weighted average interest rate for borrowings 4.03%            
Revolving Credit Facility              
Debt Instrument [Line Items]              
Weighted average interest rate for borrowings 5.83%            
Revolving credit agreement, due 2028 | Maximum              
Debt Instrument [Line Items]              
Revolver Base Rate Range           0.20%  
EuroDollar Base Rate Range           1.20%  
Revolving credit agreement, due 2028 | Minimum              
Debt Instrument [Line Items]              
Revolver Base Rate Range           0.00%  
EuroDollar Base Rate Range           0.85%  
Due 2028              
Debt Instrument [Line Items]              
Weighted average interest rate for borrowings         5.60%    
Public Bond Offering   350,000,000     $ 350,000,000    
Due 2033              
Debt Instrument [Line Items]              
Weighted average interest rate for borrowings         5.80%    
Public Bond Offering   500,000,000     $ 500,000,000    
Due 2029              
Debt Instrument [Line Items]              
Weighted average interest rate for borrowings     4.50%        
Public Bond Offering   600,000,000 $ 600,000,000 $ 600,000,000      
Revolving credit agreement, due 2028              
Debt Instrument [Line Items]              
Revolving credit agreement, due 2028 $ 220,000,000 240,000,000          
Revolving Facility Maximum Borrowing Capacity           $ 850,000,000  
Term Loan Due 2026              
Debt Instrument [Line Items]              
Term loan due 2026 $ 280,000,000 $ 280,000,000       $ 300,000,000  
Revolving Credit Agreement              
Debt Instrument [Line Items]              
Revolving credit facility             $ 850,000,000
Revolving Credit Agreement | Swing Line Loans              
Debt Instrument [Line Items]              
Revolving credit facility             $ 75,000,000
v3.25.0.1
Long-term debt - Additional Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jun. 06, 2023
Debt Instrument [Line Items]    
Revolving credit facility   $ 1,150,000
Senior notes, due 2025    
Debt Instrument [Line Items]    
Weighted average interest rate for borrowings 3.07%  
Remaining weighted average life of notes 5 months 23 days  
Senior notes, due 2025-2027    
Debt Instrument [Line Items]    
Weighted average interest rate for borrowings 3.13%  
Remaining weighted average life of notes 1 year 3 months 18 days  
Senior notes, due 2025-2030    
Debt Instrument [Line Items]    
Weighted average interest rate for borrowings 4.03%  
Remaining weighted average life of notes 2 years 5 months 8 days  
Revolving credit agreement, due 2028    
Debt Instrument [Line Items]    
Revolving Facility Maximum Borrowing Capacity   850,000
Revolving Facility Increased Maximum Borrowing Capacity   $ 922,500